Posted by ABMN Staff on May 13th, 2024
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have been assigned a consensus rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat reports. Nine analysts have rated...
More of this article »